12.73 USD
↘ 0.05 (0.42%)PRE MARKET (AS OF 07:08 AM EDT)
Shares of Atrium Therapeutics, Inc. Common Stock (RNA) are trading at $12.73. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9 and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 25, 2026.